Drosera Plex

Cough Syrup


Seroyal Usa
Human Otc Drug
NDC 62106-3126
Drosera Plex also known as Cough Syrup is a human otc drug labeled by 'Seroyal Usa'. National Drug Code (NDC) number for Drosera Plex is 62106-3126. This drug is available in dosage form of Syrup. The names of the active, medicinal ingredients in Drosera Plex drug includes Drosera Rotundifolia - 3 [hp_X]/180mL Hyoscyamus Niger - 10 [hp_X]/180mL Ipecac - 6 [hp_X]/180mL Lachesis Muta Venom - 10 [hp_X]/180mL Oregano Flowering Top - 7 [hp_X]/180mL Papaver Rhoeas Flower - 5 [hp_X]/180mL Pulsatilla Pratensis - 8 [hp_X]/180mL Rumex Crispus Root - 10 [hp_X]/180mL Spongia Officinalis Skeleton, Roasted - 10 [hp_X]/180mL Sulfur - 8 [hp_X]/180mL . The currest status of Drosera Plex drug is Active.

Drug Information:

Drug NDC: 62106-3126
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Drosera Plex
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Cough Syrup
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Seroyal Usa
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Syrup
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:DROSERA ROTUNDIFOLIA - 3 [hp_X]/180mL
HYOSCYAMUS NIGER - 10 [hp_X]/180mL
IPECAC - 6 [hp_X]/180mL
LACHESIS MUTA VENOM - 10 [hp_X]/180mL
OREGANO FLOWERING TOP - 7 [hp_X]/180mL
PAPAVER RHOEAS FLOWER - 5 [hp_X]/180mL
PULSATILLA PRATENSIS - 8 [hp_X]/180mL
RUMEX CRISPUS ROOT - 10 [hp_X]/180mL
SPONGIA OFFICINALIS SKELETON, ROASTED - 10 [hp_X]/180mL
SULFUR - 8 [hp_X]/180mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 06 Sep, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 25 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Seroyal USA
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:QR44N9XPJQ
4WRK2153H3
62I3C8233L
VSW71SS07I
7K91ZBK8GJ
Y1MLS7E68X
8E272251DI
9N1RM2S62C
1PIP394IID
70FD1KFU70
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
62106-3126-11 BOTTLE, GLASS in 1 CARTON (62106-3126-1) / 180 mL in 1 BOTTLE, GLASS06 Sep, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses for temporary cough relief.

Product Elements:

Drosera plex cough syrup pulsatilla pratensis pulsatilla pratensis spongia officinalis skeleton, roasted spongia officinalis skeleton, roasted hyoscyamus niger hyoscyamus niger lachesis muta venom lachesis muta venom papaver rhoeas flower papaver rhoeas flower caramel vitis vinifera anthocyanins adiantum capillus-veneris leaf sucrose drosera rotundifolia drosera rotundifolia oregano flowering top oregano flowering top sulfur sulfur alcohol hyssopus officinalis flowering top water ipecac ipecac rumex crispus root rumex crispus root

Indications and Usage:

Uses for temporary cough relief. directions adults take 1 tablespoon (15 ml) three to five times daily, or as recommended by your healthcare practitioner. children (over 2 years) take 1 teaspoon (5 ml) three to five times daily, or as recommended by your healthcare practitioner. children (under 2 years) take under the direction of your healthcare practitioner.

Warnings:

Warnings ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema. cough that is accompanied by excessive phlegm (mucus) or fever. stop use and ask a doctor if cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache. a persistent cough may be a sign of a serious condition. symptoms persist or worsen. if pregnant or breastfeeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions adults take 1 tablespoon (15 ml) three to five times daily, or as recommended by your healthcare practitioner. children (over 2 years) take 1 teaspoon (5 ml) three to five times daily, or as recommended by your healthcare practitioner. children (under 2 years) take under the direction of your healthcare practitioner.

Package Label Principal Display Panel:

Ndc 62106-3126-1 unda plex drosera plex cough syrup homeopathic preparation for temporary cough relief. contains 5.5% alcohol 6.1 fl oz (180 ml) 62106-3126-1


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.